Actuality

News

Dr. Joan Comella, new director of the Institut de Recerca Sant Joan de Déu

The Governing Council​ of the Institute de Recerca Sant Joan de Déu (IRSJD) has appointed Dr. Joan Comella as director of the Institute. We thank Dr. Francesc Palau for his years of dedication to the management.

  1. Pro-inflammatory alterations identified in persons with non-specific low back pain

    A study led by the Psychological Research on Fibromyalgia and Chronic Pain  Group (AGORA Group) of the Institut de Recerca Sant Joan de Déu (IRSJD) · Parc Sanitari Sant Joan de Déu and the Universitat Autònoma de Barcelona (UAB) contributes new evidence on the immune-inflammatory state in non-specific low back pain.

  2. A new European project is starting to create a European Youth Cancer Survivors Network

    The EU-funded project "EU-CAYAS-NET" will develop a "European Youth Cancer Survivors Network" alongside an interactive virtual platform, with Institut de Recerca Sant Joan de Déu participation.

  1. Dr Alexandra Avgustinova awarded a scientific excellence grant from the European Research Council (ERC)

    The ERC Starting Grant will fund the project "Oncogenic competence during development - When, Where and Why?" led by Dr Alexandra Avgustinova (IRSJD), with approximately 1.5 million euros.

  2. Device developed to facilitate monitoring of hereditary and hepatic metabolic disorders

    Drs. Rafael Artuch and Xavier Rosell, with the IRSJD, collaborate on a UAB research project, which has developed a new device capable of monitoring the patient's blood ammonium levels at any given time.

  3. Relationship of environmental exposure to nitrogen oxide with the severity of rhinovirus infection

    Researchers at Institut de Recerca Sant Joan de Déu (IRSJD) · SJD Barcelona Children's Hospital have found that exposure to higher concentrations of atmospheric nitrogen oxide in childhood is associated with greater severity of rhinovirus infection and a higher number of admissions to the Paediatric Intensive Care Unit.

  4. Science4Pandemics presents two Citizen Science projects

    The digital platform Science4Pandemics has launched two new citizen science projects for adolescents between 12 and 17 years old, as well as their parents, to collaborate with the project and provide real data for participatory research on vaccines and clinical trials.

  5. First clinical guideline on Schaaf-Yang syndrome for professionals and families

    Improving knowledge of the Schaaf-Yang syndrome (SYS) -an ultrarare disease caused by mutations in the MAGEL2 gene- is the aim of the first clinical guideline aimed at healthcare professionals and families of children affected by this pathology.

  6. CDF15 cytokine, a promising therapeutic target against type 2 diabetes

    A team led by Dr. Manuel Vázquez-Carrera, from the Institut de Recerca Sant Joan de Déu and professor Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine (IBUB) of the UB, has conducted a review study on the Growth Differentiation Factor 15 (GDF15) -a protein expressed under physiological stress conditions- and its potential impact on the treatment for type 2 diabetes.